Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

Eitemau Tebyg

• Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2
  gan: Ntemgwa, Michel L., et al.
  Cyhoeddwyd: (2009)
• Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors
  gan: Ntemgwa, Michel, et al.
  Cyhoeddwyd: (2007)
• Development of an Allele-Specific PCR for Detection of the K65R Resistance Mutation in Patients Infected with Subtype C Human Immunodeficiency Virus Type 1
  gan: Toni, Thomas A., et al.
  Cyhoeddwyd: (2010)
• Multiple Effects of the M184V Resistance Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1
  gan: Turner, Dan, et al.
  Cyhoeddwyd: (2003)
• Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  gan: Wainberg, Mark A., et al.
  Cyhoeddwyd: (2005)